150 related articles for article (PubMed ID: 18501242)
21. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
[TBL] [Abstract][Full Text] [Related]
22. Upregulated plasma and urinary levels of nucleosides as biological markers in the diagnosis of primary gallbladder cancer.
Jiao X; Mo Y; Wu Y; He J; Zhang P; Hu R; Luo C; Du J; Fu J; Shi J; Zhou L; Li D
J Sep Sci; 2014 Nov; 37(21):3033-44. PubMed ID: 25137411
[TBL] [Abstract][Full Text] [Related]
23. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
Struck-Lewicka W; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
[TBL] [Abstract][Full Text] [Related]
24. A new way to fast and high resolution determination of modified nucleosides.
Studzińska S; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():93-101. PubMed ID: 22309775
[TBL] [Abstract][Full Text] [Related]
25. Urinary nucleosides as potential tumor markers evaluated by learning vector quantization.
Dieterle F; Müller-Hagedorn S; Liebich HM; Gauglitz G
Artif Intell Med; 2003 Jul; 28(3):265-79. PubMed ID: 12927336
[TBL] [Abstract][Full Text] [Related]
26. Prediction of breast cancer using volatile biomarkers in the breath.
Phillips M; Cataneo RN; Ditkoff BA; Fisher P; Greenberg J; Gunawardena R; Kwon CS; Tietje O; Wong C
Breast Cancer Res Treat; 2006 Sep; 99(1):19-21. PubMed ID: 16502014
[TBL] [Abstract][Full Text] [Related]
27. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
28. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
29. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.
Frickenschmidt A; Frohlich H; Bullinger D; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Biomarkers; 2008 Jun; 13(4):435-49. PubMed ID: 18484357
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous determination of nucleobases, nucleosides and saponins in Panax notoginseng using multiple columns high performance liquid chromatography.
Qian ZM; Wan JB; Zhang QW; Li SP
J Pharm Biomed Anal; 2008 Dec; 48(5):1361-7. PubMed ID: 18995982
[TBL] [Abstract][Full Text] [Related]
31. A highly sensitive enzyme immunoassay for evaluation of 2'-deoxycytidine plasma level as a prognostic marker for breast cancer chemotherapy.
Darwish IA; Mahmoud AM; Aboul-Fadl T; Al-Majed AR; Khalil NY
Anal Chim Acta; 2009 Jan; 632(2):266-71. PubMed ID: 19110103
[TBL] [Abstract][Full Text] [Related]
32. Fourier transform infrared attenuated total reflection analysis of human hair: comparison of hair from breast cancer patients with hair from healthy subjects.
Lyman DJ; Murray-Wijelath J
Appl Spectrosc; 2005 Jan; 59(1):26-32. PubMed ID: 15720735
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Cho SH; Choi MH; Lee WY; Chung BC
Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
[TBL] [Abstract][Full Text] [Related]
34. [Lung cancer diagnosis based on urinary modified nucleoside metabolic profiling].
Wang WZ; Zhao XJ; Li X; Chen J; Li FL; Xu GW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):738-41. PubMed ID: 18595249
[TBL] [Abstract][Full Text] [Related]
35. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.
Seidel A; Seidel P; Manuwald O; Herbarth O
Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900
[TBL] [Abstract][Full Text] [Related]
36. Molecularly imprinted polymer of 5-methyluridine for solid-phase extraction of pyrimidine nucleoside cancer markers in urine.
Jégourel D; Delépée R; Breton F; Rolland A; Vidal R; Agrofoglio LA
Bioorg Med Chem; 2008 Oct; 16(19):8932-9. PubMed ID: 18789867
[TBL] [Abstract][Full Text] [Related]
37. Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma.
Djukovic D; Baniasadi HR; Kc R; Hammoud Z; Raftery D
Rapid Commun Mass Spectrom; 2010 Oct; 24(20):3057-62. PubMed ID: 20872639
[TBL] [Abstract][Full Text] [Related]
38. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
39. Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer?
Opitz P; Herbarth O; Seidel A; Boehm A; Fischer M; Mozet C; Dietz A; Wichmann G
Anticancer Res; 2018 Nov; 38(11):6113-6119. PubMed ID: 30396926
[TBL] [Abstract][Full Text] [Related]
40. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis.
Szymańska E; Markuszewski MJ; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2010 Dec; 53(5):1305-12. PubMed ID: 20719449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
